IN SB0262

Removes exemptions that previously allowed drugs administered directly to patients or small quantities (72-hour supply) dispensed by practitioners to be excluded from the definition of "dispense," expanding INSPECT reporting requirements

Creates new exemptions for INSPECT reporting when drugs are administered directly to a patient or when a veterinarian dispenses no more than a 72-hour supply of Schedule II-V controlled substances

Expands the definition of "prescription drug monitoring program data" to include reports on controlled substance poisonings/overdoses and information about patient participation in opioid treatment programs

Requires opioid treatment programs to obtain patient consent under federal regulations (42 CFR 2.36 and 42 CFR 2.31) before reporting patient information to INSPECT

Authorizes the Board of Pharmacy to disclose INSPECT data to the Indiana Department of Health and Family and Social Services to aid controlled substance investigations and prevent overdose events